Watchlist Price Alert

FSD Pharma Inc. (HUGE)

NASDAQ: HUGE · Real-Time Price · USD

0.09

-0.01 (-10.00%)

At close: Aug 14, 2024, 8:00 PM

FSD Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Aug 31, 2016
Cash & Equivalents	2.74M	16.98M	35.26M	17.52M	6.07M	15.52M	3.77M	7.14K
Short-Term Investments	752.23K	23.19K	158.04K	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	908.74K	827.61K	660.23K	1.68M	9.02M	13.26M	n/a	n/a
Other Long-Term Assets	5.33M	7.43M	-21.54K	-0.00	-45K	1.00	n/a	n/a
Receivables	7.42M	374.38K	500.96K	161.34K	1.58M	727.58K	234.2K	n/a
Inventory	2.00	215.00	13.56K	n/a	721.86K	2.00	1.00	n/a
Other Current Assets	n/a	n/a	8.65M	8.61M	329.47K	0.00	280.84K	n/a
Total Current Assets	11.03M	17.85M	45.93M	26.87M	8.71M	16.57M	4.28M	7.14K
Property-Plant & Equipment	119.8K	260.93K	168.31K	n/a	9.13M	8.91M	6.59M	n/a
Goodwill & Intangibles	5.36M	12.04M	16.2M	13.42M	17.12M	n/a	n/a	n/a
Total Long-Term Assets	6.36M	20.56M	17.03M	15.1M	35.27M	22.18M	6.59M	n/a
Total Assets	17.39M	38.41M	62.96M	41.97M	43.98M	38.75M	10.88M	7.14K
Account Payables	3.24M	2.76M	3M	2.06M	3.42M	1.28M	1.01M	28.31K
Deferred Revenue	-3.24M	n/a	4.52M	n/a	2.00	n/a	n/a	n/a
Short-Term Debt	300.55K	300.55K	300.55K	384.65K	1.5M	n/a	n/a	n/a
Other Current Liabilities	7.98K	243.59K	811.43K	1.61M	2.03M	n/a	n/a	n/a
Total Current Liabilities	4.54M	7.83M	8.7M	5.58M	6.95M	1.28M	1.01M	61.43K
Long-Term Debt	n/a	n/a	n/a	n/a	112.28K	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	38K	131.04K	79.12K	112.28K	1.28M	1.01M	28.31K
Total Liabilities	4.54M	7.87M	8.83M	5.66M	7.06M	1.28M	1.01M	61.43K
Total Debt	337.46K	516.42K	555.9K	510.61K	1.62M	n/a	n/a	n/a
Common Stock	137.07M	143.41M	152.32M	103.21M	75.04M	50.01M	10.34M	1.07M
Retained Earnings	-157.1M	-144.16M	-126.15M	-90.87M	-60.11M	-19.46M	-3.34M	-1.3M
Comprehensive Income	3.12M	652.6K	239.61K	207.8K	-86.27K	-183.19K	n/a	n/a
Shareholders Equity	13.17M	30.54M	54.13M	36.31M	36.92M	37.47M	9.87M	-54.3K
Total Investments	1.66M	850.8K	818.26K	1.68M	9.02M	13.26M	n/a	n/a